cNeuro 2.0

May 24, 2021

Combinostics today announced the release of cNeuro® cMRI 2.0 and cNeuro® cDSI 2.0. The main benefit of the new release is modularization of the system, facilitating the introduction of additional products to the cNeuro suite.

Recent News & Events

Combinostics and SyntheticMR to join forces

Combinostics today announced that it has entered an agreement with the Swedish company SyntheticMR where SyntheticMR, subject to approval by an Extraordinary General Meeting, will acquire all shares in Combinostics.

Combinostics cNeuro cDAT application for quantification of DAT SPECT images released in Europe

New cDAT application for for automated quantification of DAT SPECT images further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows

RSNA 2023

Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.